Phytoestrogens modulate the expression of 17α-estradiol metabolizing enzymes in cultured MCF-7 cells

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 625-632

  Wagner, Jörg ^a   Jiang, Ling ^a   Lehmann, Leane ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR; ETHOXYRESORUFIN; GENISTEIN; MESSENGER RNA; OXIDOREDUCTASE; PHYTOESTROGEN; QUERCETIN; CYTOCHROME P 450 CYP1B1; CYTOCHROME P-450 CYP1B1; ISOFLAVONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNSPECIFIC MONOOXYGENASE;

BREAST CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN MCF 7; CHEMICAL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ARTICLE; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ARYL HYDROCARBON HYDROXYLASES; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; CELL PROLIFERATION; CYTOCHROME P-450 CYP1A1; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; ISOFLAVONES; NAD(P)H DEHYDROGENASE (QUINONE); PHYTOESTROGENS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 46749123102     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_65     Document Type: Conference Paper

References (28)

1. Cavalieri E, Chakravarti D, Guttenplan J, et al. (2006) Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766: 63-78.
2. Guillemette C, Belanger A, Lepine J (2004) Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview. Breast Cancer Res 6: 246-254.
3. Badawi AF, Cavalieri EL, Rogan EG (2001) Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism 50: 1001-1003.
4. Zhu BT, Conney AH (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19: 1-27.
5. Ball P, Knuppen R (1980) Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol Suppl (Copenh) 232: 1-127.
6. Albin N, Massaad L, Toussaint C, et al. (1993) Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Cancer Res 53: 3541-3546.
7. Dawling S, Hachey DL, Roodi N, et al. (2004) In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol. Chem Res Toxicol 17: 1258-1264.
8. Danson S, Ward TH, Butler J, et al. (2004) DT-diaphorase: a target for new anticancer drugs. Cancer Treat Rev 30: 437-449.
9. Adlercreutz H, Heinonen SM, Penalvo-Garcia J (2004) Phytoestrogens, cancer and coronary heart disease. Biofactors 22: 229-236.
10. Cornwell T, Cohick W, Raskin I (2004) Dietary phytoestrogens and health. Phytochemistry 65: 995-1016.
11. Limer JL, Speirs V (2004) Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res 6: 119-127.
12. Rogan EG, Badawi AF, Devanesan PD, et al. (2003) Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 24: 697-702.
13. Singh S, Chakravarti D, Edney JA, et al. (2005) Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma. Oncol Rep 14: 1091-1096.
14. Mitrunen K, Hirvonen A (2003) Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544: 9-41.
15. Zhu BT, Liehr JG (1996) Inhibition of catechol O-methyltransferase- catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis. J Biol Chem 271: 1357-1363.
16. Spink DC, Katz BH, Hussain MM, et al. (2003) Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 24: 1941-1950.
17. Payne J, Jones C, Lakhani S, et al. (2000) Improving the reproducibility of the MCF-7 cell proliferation assay for the detection of xenoestrogens. Sci Total Environ 248: 51-62.
18. Soto AM, Sonnenschein C, Chung KL, et al. (1995) The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103 (Suppl 7): 113-122.
19. Ricci MS, Toscano DG, Mattingly CJ, et al. (1999) Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells. J Biol Chem 274: 3430-3438.
20. Safe S, Wormke M, Samudio I (2000) Mechanisms of inhibitory aryl hydrocarbon receptorestrogen receptor crosstalk in human breast cancer cells. J Mammary Gland Biol Neoplasia 5: 295-306.
21. Parvez S, Ismahan G, Raza-Bukhari A, et al. (1978) Activity of catechol-o-methyltransferase in brain regions and adrenal gland during the oestrus cycle. J Neural Transm 42: 305-312.
22. Zhu BT, Liehr JG (1994) Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol Appl Pharmacol 125: 149-158.
23. Xie T, Ho SL, Ramsden D (1999) Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56: 31-38.
24. Rasmussen TH, Nielsen JB (2002) Critical parameters in the MCF-7 cell proliferation bioassay (E-Screen). Biomarkers 7: 322-336.
25. Montano MM, Bianco NR, Deng H, et al. (2005) Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen. Front Biosci 10: 1440-1461.
26. Lee JM, Anderson PC, Padgitt JK, et al. (2003) Nrf2, not the estrogen receptor, mediates catechol estrogen-induced activation of the antioxidant responsive element. Biochim Biophys Acta 1629: 92-101.
27. Setchell KD, Faughnan MS, Avades T, et al. (2003) Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 77: 411-419.
28. Kurzer MS (2002) Hormonal effects of soy in premenopausal women and men. J Nutr 132: 570S-573S.